| 18 years and more
- | Country :
- France
- | organs :
- Prostate
- | Specialty :
- Chimiothérapie
- Thérapies Ciblées
Extract
A phase 1b/2 study to assess the safety and efficacy of AMG 102 in combination with mitoxantrone and prednisone in subjects with previously treated castrate resistant prostate cancer.
Scientific Abstract
en cours d'intégration;